Belgium’s Hyloris gets nod for post-operative pain reduction drug
HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative
HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative
HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP
HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to
By Dr K. Leelamoni October 16, 2023: Sheela, 19, a student studying medicine in India’s southern city of Thiruvananthapuram, was bitten by a
HQ Team October 13, 2023: Conflict-torn Gaza is running out of food, water, electricity and critical supplies as an Israeli blockade prevents aid
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy
HQ Team October 12, 2023: An estimated five billion people will face inadequate access to water at least a month, every year by
HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA
HQ Team October 12, 2023: A recent study conducted by Boston Children’s Hospital found that more than a third of toddlers diagnosed with